WTX-245

N/A

Report date: 2024/12/13 10:48:19
NME

Base Information

Drug NameWTX-245
Drug Alias NameWTX-245
ClassificationSmall molecules
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWaveBreak Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWaveBreak Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A